Introduction: Metabolic dysfunction-associated steatohepatitis (MASH) presents as a
complex and multifactorial liver disorder characterized by inflammation, hepatocyte injury …

Metabolic dysfunction-associated steatotic liver disease (MASLD) and its progressive form,
metabolic dysfunction-associated steatohepatitis (MASH), pose significant risks of severe …

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and its severe clinical
form, metabolic dysfunctionassociated steatohepatitis (MASH), are chronic liver diseases …

Metabolic dysfunction–associated steatohepatitis (MASH) is a severe form of liver disease
that poses a global health threat because of its potential to progress to advanced fibrosis …

Metabolic dysfunction-associated steatotic liver disease (MASLD) affects a significant
portion of the human population, potentially leading to severe secondary conditions. Despite …

Liver transcriptomic data from patients with metabolic dysfunction-associated steatotic liver
disease (MASLD) offers valuable resource for deciphering pathogenic molecular drivers …

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the commonest cause
of chronic liver disease worldwide and represents an unmet precision medicine challenge …

Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is a prevalent
chronic liver disease worldwide, and can rapidly progress to metabolic dysfunction …

METHODS: We analysed 2,941 plasma proteins in 43,978 European participants from UK
Biobank. We performed genome-wide association study (GWAS) for all MASLD-associated …

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common
chronic liver disease worldwide, affecting more than one in four people, and is the leading …